In vitro acetylcholinesterase inhibition by psoralen using molecular docking and enzymatic studies

INTRODUCTION: Alzheimer's disease (AD) has increased at an alarming rate and is now a worldwide health problem. Inhibitors of acetylcholinesterase (AChE) leading to inhibition of acetylcholine breakdown constitute the main therapeutic strategy for AD. Psoralen was investigated as inhibitor of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Somani, Gauresh, Kulkarni, Chinmay, Shinde, Prashant, Shelke, Rupesh, Laddha, Kirti, Sathaye, Sadhana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333625/
https://www.ncbi.nlm.nih.gov/pubmed/25709334
http://dx.doi.org/10.4103/0975-7406.148775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333625/
https://www.ncbi.nlm.nih.gov/pubmed/25709334
http://dx.doi.org/10.4103/0975-7406.148775

Ejemplares similares